Every vacay outfit deserves a shoe that's cute *and* comfortable for walking around all day and night. View Entire Post › ...

From sandals to sneakers, these will let you enjoy a full day of sightseeing without having to find somewhere to sit every ten minutes. Imagine that. View Entire Post › ...

Teva stock catapulted Tuesday after its inflammatory bowel disease treatment showed "best-in-class potential" in a Phase 2 study. Researchers Found A Link Between This Childhood Virus And ...

On Tuesday, Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) and Sanofi SA’s (NASDAQ:SNY) Phase 2b RELIEVE UCCD study met its primary endpoints in patients with ulcerative colitis (UC ...

Merck is working on the monoclonal antibody MK-7240—formerly known as PRA023—which it acquired in its $10.8 billion buyout of Prometheus Biosciences last year. In phase 2 results disclosed in ...

JERUSALEM, Dec 17 (Reuters) - (This Dec.17 story has been corrected to say the results were for ulcerative colitis, not for both the diseases, in paragraph 5) Teva and Sanofi said last year they ...

Duvakitug isn't just another drug in Teva's pipelineit's the drug. With consistent efficacy across patient groups and no major safety hiccups, this TL1A antibody therapy is now a frontrunner in ...

A Teva Pharmaceuticals drug being developed in partnership with Sanofi to hit a promising but competitive target for inflammation now has positive data from a clinical test in the two most common ...

Holders England will play their predecessors as champions Netherlands while hosts Switzerland will take on Norway, Iceland and Finland after the UEFA Women's EURO 2025 draw was made at the Swiss ...

Want to know the latest about research funded by the National Institutes of Health on topics including menopause, polycystic ovary syndrome and other conditions affecting women’s health?

Army veterans who spoke to CBS News are concerned Hegseth would seek to reinstate a ban that would bar women from serving ... Army allowed soldiers to run in shoes, rather than boots.